Table 1.
Characteristics of Analyzed Patients After Achieving HIV Suppression on Antiretroviral Therapy
| Characteristic | Overall (N = 6036) | NHL (n = 37) | No NHL (n = 5999) |
|---|---|---|---|
| Male sex | 4824 (80%) | 34 (92%) | 4790 (80%) |
| White race | 3104 (51%) | 22 (60%) | 3082 (51%) |
| Men who have sex with men | 3386 (56%) | 21 (57%) | 3365 (56%) |
| Hepatitis B virus | 397 (7%) | 3 (8%) | 394 (7%) |
| Hepatitis C virus | 801 (13%) | 9 (24%) | 792 (13%) |
| Age, y | 39 (33–46) | 42 (39–46) | 39 (33–46) |
| ART initiation year | 2005 (2002–2008) | 2003 (2001–2005) | 2005 (2002–2008) |
| Time from ART initiation to HIV suppression, mo | 1.9 (1.1–3.3) | 1.9 (1.0–3.1) | 1.9 (1.1–3.3) |
| Peak pre-ART HIV viremiaa, log10 copies/mL | 5.0 (4.6–5.5) | 5.4 (5.0–5.7) | 5.0 (4.6–5.5) |
| Peak HIV viremia after ART initiationb, log10 copies/mL | 2.6 (1.9–4.3) | 2.7 (2.3–4.8) | 2.6 (1.9–4.3) |
| Nadir CD4 cell counta, cells/µL | 180 (50–280) | 100 (30–250) | 180 (50–280) |
| CD4 cell count at HIV suppression, cells/µL | 290 (160–430) | 160 (70–350) | 290 (160–430) |
Data are presented as No. (%) or median (interquartile range).
Abbreviations: ART, antiretroviral therapy; HIV, human immunodeficiency virus; NHL, non-Hodgkin lymphoma.
a One hundred three (2%) missing peak pre-ART HIV viremia and 29 (<1%) missing nadir CD4 cell count.
b Highest HIV RNA level at any time during study follow-up.